TRENTINI, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 273
NA - Nord America 157
AS - Asia 33
OC - Oceania 3
Totale 466
Nazione #
US - Stati Uniti d'America 157
IT - Italia 124
IE - Irlanda 52
SE - Svezia 27
AT - Austria 19
DE - Germania 15
CN - Cina 14
IN - India 13
FI - Finlandia 10
GB - Regno Unito 5
LU - Lussemburgo 4
RU - Federazione Russa 4
UA - Ucraina 4
AU - Australia 3
BE - Belgio 2
BG - Bulgaria 2
HK - Hong Kong 2
JP - Giappone 2
MD - Moldavia 2
SG - Singapore 2
LT - Lituania 1
MK - Macedonia 1
PL - Polonia 1
Totale 466
Città #
Dublin 52
Chandler 39
Ashburn 26
Vienna 19
Bologna 17
Parma 17
Verona 14
New York 13
Ann Arbor 11
Shanghai 10
West Jordan 8
Milan 7
Helsinki 6
Bolzano 5
Reggio Emilia 5
Trento 5
Boardman 4
Bremen 4
Collecchio 3
Houston 3
Lonato 3
Melbourne 3
Princeton 3
Pune 3
San Giuliano Milanese 3
Assago 2
Brussels 2
Central 2
Chisinau 2
Fremont 2
Grafing 2
Hyderabad 2
Marino 2
Nakanishi 2
Piacenza 2
Rio Saliceto 2
Sassuolo 2
Sissa 2
Sofia 2
Torrile 2
Viggiù 2
Zevio 2
Alessandria 1
Arezzo 1
Atlanta 1
Castiglione Dei Pepoli 1
Cavallino-Treporti 1
Des Moines 1
Empoli 1
Florence 1
Frankfurt am Main 1
Gdansk 1
Hangzhou 1
London 1
Mondavio 1
Nürnberg 1
Orzinuovi 1
Philadelphia 1
Redmond 1
Seattle 1
Trieste 1
Vilnius 1
Totale 337
Nome #
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 109
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors 67
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 59
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients 57
1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy 53
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens 40
BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients 24
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 22
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score 21
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 11
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 11
P57.08 High Performance Radiomic Classifier to Predict the Response to Immunotherapy in Advanced NSCLC 4
Totale 478
Categoria #
all - tutte 1.822
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.822


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 3 1 20 5
2021/202245 5 4 2 1 0 4 12 2 0 0 5 10
2022/2023235 19 15 8 23 36 29 7 17 60 1 9 11
2023/2024169 9 22 3 13 19 31 27 10 15 20 0 0
Totale 478